It has been about a month since the last earnings report for Xylem (XYL - Free Report) . Shares have added about 8.5% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Xylem due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Xylem's Q3 Earnings Meet, Revenues Miss Estimates
Xylem reported mixed results for third-quarter 2018, wherein adjusted earnings came in line with estimates but revenues missed the Consensus mark.
The company’s quarterly adjusted earnings of 77 cents per share came in line with the Zacks Consensus Estimate. The bottom line jumped 18.5% from the prior-year quarter.
Quarterly revenues came in at $1,287 million, missing the Zacks Consensus Estimate of $1,296 million. However, the top line improved 7.7% year over year.
Revenues in the Water Infrastructure segment came in at $541 million, up 4% year over year. This upside stemmed from improved utilities as well as industrial end-market demand.
Applied Water segment generated revenues of $378 million in the third quarter, up 6.8% year over year. This upswing stemmed from robust commercial end-market business as well as strong industrial end-market business in the United States.
Quarterly revenues of the Measurement & Control Solutions segment came in at $368 million, up 14.6% year over year. This improvement stemmed from robust Sensus as well as growth in water sector business in North America.
Xylem’s cost of revenues in the third quarter was $782 million, up 8% year over year. Gross profit margin was 39.2%, down 20 basis points (bps).
Selling, general and administrative expenses totaled $279 million, up from $270 million incurred a year ago. R&D expenses were $46 million compared with $45 million incurred in the year-ago quarter. Adjusted operating margin in the quarter under review was 14.6%, up 50.
Balance Sheet and Cash Flow
Xylem exited the third quarter with cash and cash equivalents of $404 million compared with $414 million as of Dec 31, 2017. Long-term debt was $2,189 million compared with $2,200 million at the end of 2017.
In the first nine months of 2018, Xylem generated $388 million cash from operating activities, higher than $379 million in the comparable period last year. Capital expenditure was $171 million compared with $119 million incurred in the year-earlier period.
Xylem stated that its pricing actions and stronger productivity will help mute the impact of prevailing headwinds owing to material cost inflation.
The company currently expects generating revenues of roughly $5.2 billion in 2018, estimating organic revenue growth of 7-8%. In addition, the adjusted earnings for the current year has been revised to $2.87-$2.89 per share from the earlier guidance of $2.85-$2.95.
How Have Estimates Been Moving Since Then?
Fresh estimates followed a downward path over the past two months.
At this time, Xylem has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Xylem has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.